000 01412 a2200409 4500
005 20250514050516.0
264 0 _c20021114
008 200211s 0 0 eng d
022 _a0028-3878
024 7 _a10.1212/wnl.59.8.1210
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSandrini, G
245 0 0 _aEletriptan vs sumatriptan: a double-blind, placebo-controlled, multiple migraine attack study.
_h[electronic resource]
260 _bNeurology
_cOct 2002
300 _a1210-7 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIndoles
_xadverse effects
650 0 4 _aLogistic Models
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMigraine Disorders
_xdrug therapy
650 0 4 _aPyrrolidines
_xadverse effects
650 0 4 _aRemission Induction
650 0 4 _aSerotonin Receptor Agonists
_xadverse effects
650 0 4 _aSumatriptan
_xadverse effects
650 0 4 _aTryptamines
700 1 _aFärkkilä, M
700 1 _aBurgess, G
700 1 _aForster, E
700 1 _aHaughie, S
773 0 _tNeurology
_gvol. 59
_gno. 8
_gp. 1210-7
856 4 0 _uhttps://doi.org/10.1212/wnl.59.8.1210
_zAvailable from publisher's website
999 _c12200311
_d12200311